APA (7th ed.) Citation

Eckstein, F., Kraines, J. L., Aydemir, A., Wirth, W., Maschek, S., & Hochberg, M. C. (2020). Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: Post-hoc analysis of a randomised, placebo-controlled phase II clinical trial. Annals of the rheumatic diseases, 79(4), 525-528. https://doi.org/10.1136/annrheumdis-2019-216453

Chicago Style (17th ed.) Citation

Eckstein, Felix, Jeffrey L. Kraines, Aida Aydemir, Wolfgang Wirth, Susanne Maschek, and Marc C. Hochberg. "Intra-articular Sprifermin Reduces Cartilage Loss in Addition to Increasing Cartilage Gain Independent of Location in the Femorotibial Joint: Post-hoc Analysis of a Randomised, Placebo-controlled Phase II Clinical Trial." Annals of the Rheumatic Diseases 79, no. 4 (2020): 525-528. https://doi.org/10.1136/annrheumdis-2019-216453.

MLA (9th ed.) Citation

Eckstein, Felix, et al. "Intra-articular Sprifermin Reduces Cartilage Loss in Addition to Increasing Cartilage Gain Independent of Location in the Femorotibial Joint: Post-hoc Analysis of a Randomised, Placebo-controlled Phase II Clinical Trial." Annals of the Rheumatic Diseases, vol. 79, no. 4, 2020, pp. 525-528, https://doi.org/10.1136/annrheumdis-2019-216453.